DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / A••••••• N•••••••••
A••••••• N•••••••••
Series BUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $31.0Msum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Jun 2, 2026Series B · $31.0M (disclosed)T•• F••• (participant)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “A••••••• N••••••••• Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment”
Investors on record
1 edges
- T•• F••• round, participant Fact prnewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Jun 2, 2026A••••••• N••••••••• announced Series B of $31,000,000Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Series B $31,000,000 Jun 2, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)